GlycoMimetics to Present at Two Upcoming Healthcare Investor Conferences
11/09/2021 - 09:00 AM
ROCKVILLE, Md. --(BUSINESS WIRE)--
GlycoMimetics, Inc. (Nasdaq: GLYC), today announces that Chief Executive Officer Harout Semerjian will present an overview of the company at the upcoming Stifel 2021 Virtual Healthcare Conference on Monday, November 15 and the Jefferies London Healthcare Conference on Wednesday, November 17 . Both presentations will be available on the Company’s website, under the Investors tab. Details are as follows:
Stifel 2020 Virtual Healthcare Conference
November 15-17, 2021
GlycoMimetics presentation: Monday, November 15 , 3:20 p.m. (ET)
Jefferies London Healthcare Conference
November 16-19, 2021
GlycoMimetics presentation: Wednesday, November 17 , 11:20 AM GMT (6:20 AM ET )
About GlycoMimetics, Inc.
GlycoMimetics is a clinical-stage biotechnology company discovering and developing glycobiology-based therapies for cancers, including acute myeloid leukemia (AML), and for inflammatory diseases with high unmet need. The Company’s science is based on an understanding of the role that carbohydrates play on the surface of every living cell and applying its specialized chemistry platform to discover small molecule drugs, known as glycomimetics, which alter these carbohydrate-mediated pathways in a variety of disease states, including signaling in cancer and inflammation. As a leader in this space, GlycoMimetics is leveraging this unique targeted approach to advance its pipeline of wholly owned drug candidates, with the goal of developing transformative therapies for serious diseases. GlycoMimetics is located in Rockville, MD in the BioHealth Capital Region . Learn more at www.glycomimetics.com .
View source version on businesswire.com : https://www.businesswire.com/news/home/20211109006046/en/
Investor Contact:
Shari Annes
sannes@annesassociates.com
Media Contact:
Jamie Lacey-Moreira
jamielacey@presscommpr.com
Source: GlycoMimetics, Inc.
GLYC Rankings
#251 Ranked by Stock Gains
GLYC Stock Data
Industry
Pharmaceutical Preparation Manufacturing
Sector
Manufacturing
Tags
Health Technology, Biotechnology, Manufacturing, Pharmaceutical Preparation Manufacturing
Country
US
City
Rockville
About GLYC
at glycomimetics, we are committed to helping to make a difference in the lives of people living with sickle cell, cancer, and other serious diseases. our mission is to continue to advance our research and clinical candidates, providing hope for patients as we strive for tomorrow’s breakthrough treatments. glycomimetics is a clinical-stage biotechnology company. we use novel and proprietary glycobiology technology to develop treatments for diseases, particularly where there is high unmet need. since the company’s inception in 2003, we have developed a robust, diversified product pipeline. we are a public company traded on the nasdaq under the symbol glyc.
